Literature DB >> 25154654

Tibiocalcaneal arthrodesis in the high-risk foot.

Guido A LaPorta1, Ellianne M Nasser2, Jennifer L Mulhern3.   

Abstract

The present case series outlines the history and surgical treatment of 6 patients who underwent tibiocalcaneal arthrodesis from April 2002 to May 2012, all with external fixation as the primary or secondary fixation. Surgical intervention was performed by the same surgeon at the same facility. The indication for surgery was a nonbraceable Charcot deformity in 5 (83.3%) patients and bone and soft tissue infection complicating previous intramedullary hindfoot fusion in 1 (16.7%) patient. Talectomy was performed in 2 (33.3%) patients secondary to widespread osteomyelitis of the talus and in 4 (66.7%) patients secondary to avascular necrosis and/or disintegration and fragmentation of the remaining talus. The postoperative complications have been discussed in detail and their management outlined. At the most recent follow-up visit, all patients were independently ambulating on a braceable limb with or without the use of an assistive device. In conclusion, tibiocalcaneal arthrodesis is a reasonable option for limb salvage to produce community ambulators in the high-risk population. We emphasize that although multiple fixation options are available for tibiocalcaneal arthrodesis, a combination of internal and external fixation is vital to its success.
Copyright © 2014 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Charcot; external fixation; joint fusion; talectomy; tibiocalcaneal fusion

Mesh:

Year:  2014        PMID: 25154654     DOI: 10.1053/j.jfas.2014.06.027

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  1 in total

1.  Tibiocalcaneal arthrodesis using the Ilizarov fixator in compromised hosts: an analysis of 19 patients.

Authors:  Charlotte Reinke; Sebastian Lotzien; Emre Yilmaz; Yannik Hanusrichter; Christopher Ull; Hinnerk Baecker; Thomas A Schildhauer; Jan Geßmann
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-23       Impact factor: 2.928

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.